{"database": "lobbying", "table": "lobbying_activities", "rows": [[1109133, "e3716adb-e53e-4d18-b5fd-b2ce6ad324fe", "Q2", "HOLLAND & KNIGHT LLP", 18466, "ALLIANCE FOR REGENERATIVE MEDICINE", 2011, "second_quarter", "HCR", "Advocate for funding for regenerative medicine companies;  NIH funding for regenerative medicine research; funding for FDA to perform regulatory research and creation of federal coordinating entity for regenerative medicine.  Advocate for new/modified regulations re:  FDA aprroval of regenerative medicine products.  Met with NIST to explore collaborations re: manfacturing standards; Lobbied in support of HR 1862, The Regenerative Medicine Promotion Act of 2011", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),Natl Institutes of Health (NIH),SENATE", 80000, null, 0, 0, "2011-07-11T11:49:36.593000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1109133"], "units": {}, "query_ms": 0.38568105082958937, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}